FLASHBACK: Tim Walz’s Health Department Devised COVID-19 Plan That Prioritized Blacks Over Whites

The Minnesota Department of Health (MDH) under Democratic Gov. Tim Walz, now his party’s presumptive vice presidential nominee, used race to determine who could receive potentially life-saving medication during the COVID-19 pandemic, documents show.

In 2021, Minnesota adopted a framework, which they later reformed following pushback, that assigned points based on various personal attributes to ration monoclonal antibodies, a COVID-19 treatment that was in short supply at the time, according to state documents. Under the state’s point system, a healthy 25-year-old black person, for instance, would have been put in front of a 55-year-old white person with hypertension or a 64-year-old white person to receive monoclonal antibodies during the pandemic due to their race.

People falling under “BIPOC status,” which refers to black, indigenous and people of color, were awarded two points through the framework, having been given the same weight as cardiovascular disease, obesity and diabetes, all known comorbidities for the virus. Monoclonal antibodies are a treatment for COVID-19 administered via infusion that can reduce the risk of hospitalization or severe illness.

Walz had direct influence over his state’s health department as, in Minnesota, the governor is responsible for appointing the MDH’s commissioner, according to MinnPost. Minnesota leaned on the Biden-Harris administration to justify its policies, citing the Food and Drug Administration (FDA) in its framework documents to explain why it was using racial discrimination to distribute life-saving medication.